Evidence map›Paper›PMID 40369337›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026

Culturally Adapted Shared Decision-Making Tool for Breast Cancer Clinical Trials in China: A Nurse-Led Approach.

Ting Lu, Junxia Xu, Qingrong Cao, Jing Zhang, Jian Chen, Lin Lin, Benjie Shan, Jie Wei

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ting LuDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China. Luting860130@outlook.com.
Junxia XuDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Qingrong CaoDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Jing ZhangDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Jian ChenDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Lin LinDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Benjie ShanDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Jie WeiDepartment of Comprehensive Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to develop and validate a culturally adapted, nurse-led shared decision-making question prompt list (SDM-QPL) to enhance decision-making support for Chinese breast cancer patients considering clinical trials. A mixed-methods approach was employed, involving a systematic literature review (52 studies), semi-structured interviews with 15 patients and 8 healthcare providers, a three-round Delphi consensus with 13 experts, and psychometric testing. The process yielded a 40-item QPL tailored to cultural needs, such as familial decision-making and Traditional Chinese Medicine (TCM) use. The SDM-QPL, organized into five modules, achieved strong expert consensus (Kendall's W = 0.82, P < 0.001) and retained 92% of nurse-sensitive items. Psychometric evaluation confirmed high validity (S-CVI/Ave = 0.89) and reliability (Cronbach's α = 0.91). Qualitative analysis identified key barriers: information overload (93.3%), risk misperceptions (86.7%), and nursing communication gaps (80.0%). This nurse-led SDM-QPL, grounded in Elwyn's Three-Talk Model, addresses China's unique cultural and structural challenges, fostering triadic dialogue among patients, families, and providers. The tool empowers oncology nurses to bridge communication gaps, improve trial participation equity, and support patient-centered care in collectivist settings.

Indexed as

Breast NeoplasmsClinical Trials as TopicDecision Making, SharedPatient ParticipationAdultChinaCulturally Competent CareDecision MakingDelphi TechniqueFemaleHumansMiddle AgedPsychometricsReproducibility of ResultsBreast cancerClinical trialsCultural adaptationOncology nursingQuestion prompt listShared decision-making

Identifiers

PMID40369337

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.